Yancheng City Donggang Pharmaceutical Development Co., Ltd., established in 2003, primarily produces pharmaceutical intermediates and other fine chemicals. Among its products, the intermediates for the non-steroidal anti-inflammatory analgesic drug naproxen—acetonaphthone, the sertraline intermediate—tetralone, and bronopol are all highly renowned in the industry.

Donggang Pharma adheres to the corporate philosophy of "professionalism, dedication, innovation, and win-win cooperation," focusing on producing specialized fine chemicals while striving for continuous innovation in technology and management to maintain a leading position, thereby achieving mutual growth with customers. We consistently fulfill our social responsibilities in environmental protection, safety, health, and occupational hygiene, taking the shared progress of the company, regional economy, employees, and customers as our mission.

Our quality policy is "excellent appearance, superior internal quality, thoughtful service, and a strong quality awareness." The company has established a rigorous quality and service system. We have obtained ISO 9001 quality management system certification and ISO 14001 environmental management system certification, and have been granted the right to self-manage import and export. Our products are exported to most countries and regions around the world, and we have established long-term, stable cooperative relationships with several internationally renowned chemical giants. Our product quality has received consistent praise from customers.

Donggang Pharma currently has six standard workshops equipped with ample power facilities, refrigeration equipment, heating systems, and other utilities. The company is equipped with 150 stainless steel and glass-lined reactors ranging from 100L to 5,000L, capable of carrying out various reactions under temperature conditions from -25°C to 300°C and pressure conditions from full vacuum to 0.3 MPa. The company has accumulated valuable experience in reactions such as bromination, Friedel-Crafts acylation, diazotization, hydrogenation, Grignard reaction, and others.

In May 2010, Donggang Pharma established Zhangjiagang Jiumu Technology Co., Ltd., and has built long-term cooperative relationships with multiple domestic research institutes. The company has a professional R&D team dedicated to the development of new products. Thanks to its commitment to innovation, dedication to pioneering efforts, and persistent pursuit of product improvement and new product development, the company possesses strong technical expertise and innovation capabilities, enabling superior production technology for its products.